Keywords
prostate neoplasm - castration-resistant prostate neoplasm - abiraterone acetate
Bibliographical Record
Ana Rafaela Nascimento e Bouças, Monalisa Ceciliana Freitas Moreira de Andrade, Rodrigo
Jerônimo de Araújo, Sulene Cunha Sousa Oliveira, Sofia Bezerra Rocha, Kleyton Santos
Medeiros, Gabriela Miranda Sá, Aline Alves Soares, Luciana Câmara da Silva, Isa Leandro
Soares, Menilla Maria Alves de Melo, Andrea Juliana Pereira de Santana Gomes. Low-dose
versus standard-dose abiraterone in metastatic castration-resistant prostate cancer
post-docetaxel: randomized controlled trial in Brazil (Dumont). Brazilian Journal
of Oncology 2025; 21.
DOI: 10.1055/s-0045-1808048
